Evidence map›Paper›PMID 25554228›Full record

ReviewBiochimica et biophysica acta2015

You are lost without a map: Navigating the sea of protein structures.

Audrey L Lamb, T Joseph Kappock, Nicholas R Silvaggi

Abstract readReview
In one paragraph

Review in Biochimica et biophysica acta, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Reuniting crystallography with real space: Ab initio structure elucidation with 4D-STEM.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Article
  9. Journal of applied crystallography · 2024
    Article
  10. Article
  11. MatchMaps: Non-isomorphous difference maps for X-ray crystallography.bioRxiv : the preprint server for biology · 2024
    Article
  12. Review
  13. Article
  14. Article
  15. 'International journal of molecular sciences · 2021
    Article
  16. Article
  17. Article
  18. Review
  19. Tools for ligand validation in Coot.Acta crystallographica. Section D, Structural biology · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Audrey L LambDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS 66045, United States. Electronic address: lamb@ku.edu.
T Joseph KappockDepartment of Biochemistry, Purdue University, West Lafayette, IN 47907, United States.
Nicholas R SilvaggiDepartment of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, United States. Electronic address: silvaggi@uwm.edu.

Funding

X-ray Absorption Spectroscopy (XAS) pp.711-759P41GM103393 · NIGMS · STANFORD UNIVERSITY · PI HODGSON, KEITH O · 2012 to 2019
$30.6M
Structure-function analyses of siderophore biosynthetic enzymesK02AI093675 · NIAID · UNIVERSITY OF KANSAS LAWRENCE · PI LAMB, AUDREY L · 2011 to 2014
$428k
NIAID NIH HHS K02 AI093675NIGMS NIH HHS P41 GM103393NIGMS NIH HHS P41GM103393
6 · The paper itself

Abstract

X-ray crystal structures propel biochemistry research like no other experimental method, since they answer many questions directly and inspire new hypotheses. Unfortunately, many users of crystallographic models mistake them for actual experimental data. Crystallographic models are interpretations, several steps removed from the experimental measurements, making it difficult for nonspecialists to assess the quality of the underlying data. Crystallographers mainly rely on "global" measures of data and model quality to build models. Robust validation procedures based on global measures now largely ensure that structures in the Protein Data Bank (PDB) are largely correct. However, global measures do not allow users of crystallographic models to judge the reliability of "local" features in a region of interest. Refinement of a model to fit into an electron density map requires interpretation of the data to produce a single "best" overall model. This process requires inclusion of most probable conformations in areas of poor density. Users who misunderstand this can be misled, especially in regions of the structure that are mobile, including active sites, surface residues, and especially ligands. This article aims to equip users of macromolecular models with tools to critically assess local model quality. Structure users should always check the agreement of the electron density map and the derived model in all areas of interest, even if the global statistics are good. We provide illustrated examples of interpreted electron density as a guide for those unaccustomed to viewing electron density.

Indexed as

Databases, ProteinProtein ConformationProtein Interaction MapsCrystallography, X-RayElectronsHumansLigandsMacromolecular SubstancesModels, MolecularProteinsLigandsMacromolecular SubstancesProteinsAtomic coordinate filesAtomic displacement parametersElectron density mapsMolecular modelsProtein structureX-ray crystallography

Identifiers

PMID25554228
PMCPMC5051661

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.